0001178913-20-001753.txt : 20200608
0001178913-20-001753.hdr.sgml : 20200608
20200608060626
ACCESSION NUMBER: 0001178913-20-001753
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200512
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harel Insurance Co LTD
CENTRAL INDEX KEY: 0001666482
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 20948030
BUSINESS ADDRESS:
STREET 1: ABBA HILLEL 3
CITY: RAMAT GAN
STATE: L3
ZIP: 5211802
BUSINESS PHONE: 97237547090
MAIL ADDRESS:
STREET 1: ABBA HILLEL 3
CITY: RAMAT GAN
STATE: L3
ZIP: 5211802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harel Insurance Investments & Financial Services Ltd.
CENTRAL INDEX KEY: 0001429390
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 20948031
BUSINESS ADDRESS:
STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST.
CITY: RAMAT GAN
STATE: L3
ZIP: 52118
BUSINESS PHONE: 972-3-7547090
MAIL ADDRESS:
STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST.
CITY: RAMAT GAN
STATE: L3
ZIP: 52118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4/A
1
ownership.xml
X0306
4/A
2020-05-12
2020-05-14
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001666482
Harel Insurance Co LTD
3 ABA HILLEL ROAD STREET
RAMAT GAN
L3
52118
ISRAEL
0
0
1
0
0001429390
Harel Insurance Investments & Financial Services Ltd.
3 ABA HILLEL ROAD STREET
RAMAT GAN
L3
52118
ISRAEL
0
0
1
0
Common Stock, par value $0.01 per share
1663834
I
See footnotes
On May 14, 2020, Harel Insurance Investments & Financial Services Ltd. ("Harel Holdings") and Harel Insurance Company Ltd., a wholly owned subsidiary of Harel Holdings ("Harel Insurance" and, together with Harel Holdings, the "Reporting Persons"), filed a Form 4 (the "Form 4"). The Form 4 inadvertently reported the purchase of 500,000 shares of Common Stock of the Issuer that, as described in footnote 4 to the Form 4, were acquired and are held for members of the public through, among others, provident funds and/or mutual funds and/or pension funds and/or insurance policies and/or exchange traded funds (together, the "Public Shares"), which Public Shares are managed by wholly owned subsidiaries of the Reporting Persons, each of which subsidiaries operates under independent management and makes independent voting and investment decisions.
Continued from Footnote (1): In accordance with Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended, the Reporting Persons do not have any direct or indirect pecuniary interest in the Public Shares or any transactions therein. Accordingly, this amendment to the Form 4 is being made to correct that inadvertent error by removing the purchase of the 500,000 Public Shares from the Form 4. As a result, and after giving effect to this amendment, the correct amount of shares of Common Stock of the Issuer beneficially owned by the Reporting Persons is 1,663,834 shares.
Pursuant to Instruction 9 to Form 4, the Reporting Persons have omitted from this amendment to the Form 4 the transaction information with respect to the other shares of the Issuer that were reported in the initial filing of the Form 4 and which are not being amended hereby.
HAREL INSURANCE COMPANY LTD. BY: /s/ Uri Rabinovitz, Vice President
2020-06-08
HAREL INSURANCE INVESTMENTS AND FINANCIAL SERVICES LTD. BY: /s/ Uri Rabinovitz, Vice President
2020-06-08